Tempus AI's Accounting Chief Just Reported an Insider Transaction. Here's What Long-Term Investors Should Know
Bartolucci disposed of shares valued at $306,342 to cover statutory withholding obligations tied to RSU vesting, retaining direct holdings of 67,866 shares worth $3.35 million.
Tempus AI's Chief Accounting Officer, Ryan M. Bartolucci, recently reported the sale of 6,175 shares of the company's Class A Common Stock. The transaction, disclosed in a recent SEC Form 4 filing, valued the shares at an average price of $49.61 per share on August 18. However, the post-transaction market value was slightly lower at $49.36 per share as of the same day.
Tempus AI, a healthcare technology firm with a market capitalization of $10.7 billion, provides AI-driven diagnostic and analytics solutions for precision medicine. The company's innovative platform architecture, which integrates clinical workflow optimization, proprietary laboratory capabilities, and advanced data analytics, gives it a competitive edge.
Tempus AI currently employs 3,800 people and is headquartered in Chicago. Despite its significant position in the industry, the company is currently experiencing growth and operates with a negative net income of -$254.4 million on a trailing twelve-month basis.
Written by urgent.news from Motley Fool's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.